These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8123474

  • 1. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
    Citro G, Szczylik C, Ginobbi P, Zupi G, Calabretta B.
    Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
    Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G, Calabretta B.
    Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):7031-5. PubMed ID: 1495997
    [Abstract] [Full Text] [Related]

  • 3. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P, Geiser TA, Ombres D, Citro G.
    Anticancer Res; 1997 Aug 01; 17(1A):29-35. PubMed ID: 9066627
    [Abstract] [Full Text] [Related]

  • 4. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
    Del Bufalo D, Cucco C, Leonetti C, Citro G, D'Agnano I, Benassi M, Geiser T, Zon G, Calabretta B, Zupi G.
    Br J Cancer; 1996 Aug 01; 74(3):387-93. PubMed ID: 8695353
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
    Szczylik C, Skórski T, Malaguarnera L, Hetman J, Chen ST, Calabretta B.
    Folia Histochem Cytobiol; 1996 Aug 01; 34(3-4):129-34. PubMed ID: 8967957
    [Abstract] [Full Text] [Related]

  • 6. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G, Gewirtz AM.
    Proc Natl Acad Sci U S A; 1992 Dec 15; 89(24):11823-7. PubMed ID: 1281545
    [Abstract] [Full Text] [Related]

  • 7. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
    Anfossi G, Gewirtz AM, Calabretta B.
    Proc Natl Acad Sci U S A; 1989 May 15; 86(9):3379-83. PubMed ID: 2541445
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
    Raschellà G, Negroni A, Skorski T, Pucci S, Nieborowska-Skorska M, Romeo A, Calabretta B.
    Cancer Res; 1992 Aug 01; 52(15):4221-6. PubMed ID: 1638535
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.
    J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233
    [Abstract] [Full Text] [Related]

  • 10. Receptor-mediated oligodeoxynucleotides delivery by estradiol and folic acid polylysine conjugates.
    Citro G, Ginobbi P, Szczylik C.
    Cytotechnology; 1993 Apr 03; 11 Suppl 1():S30-4. PubMed ID: 7764059
    [Abstract] [Full Text] [Related]

  • 11. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty.
    Gunn J, Holt CM, Francis SE, Shepherd L, Grohmann M, Newman CM, Crossman DC, Cumberland DC.
    Circ Res; 1997 Apr 03; 80(4):520-31. PubMed ID: 9118483
    [Abstract] [Full Text] [Related]

  • 12. Antisense src expression inhibits U937 human leukemia cell proliferation in conjunction with reduction of c-myb expression.
    Waki M, Kitanaka A, Kamano H, Tanaka T, Kubota Y, Ohnishi H, Takahara J, Irino S.
    Biochem Biophys Res Commun; 1994 Jun 15; 201(2):1001-7. PubMed ID: 7516155
    [Abstract] [Full Text] [Related]

  • 13. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H.
    Neurosurgery; 1997 Oct 15; 41(4):908-15. PubMed ID: 9316053
    [Abstract] [Full Text] [Related]

  • 14. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.
    Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD.
    Nature; 1992 Sep 03; 359(6390):67-70. PubMed ID: 1522889
    [Abstract] [Full Text] [Related]

  • 15. Effects of the antisense v-myb' expression on K562 human leukemia cell proliferation and differentiation.
    Kamano H, Ohnishi H, Tanaka T, Ikeda K, Okabe A, Irino S.
    Leuk Res; 1990 Sep 03; 14(10):831-9. PubMed ID: 1979645
    [Abstract] [Full Text] [Related]

  • 16. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
    Yen A, Samuel V, Forbes M.
    J Cell Physiol; 1992 Oct 03; 153(1):147-56. PubMed ID: 1522128
    [Abstract] [Full Text] [Related]

  • 17. Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis.
    Caracciolo D, Venturelli D, Valtieri M, Peschle C, Gewirtz AM, Calabretta B.
    J Clin Invest; 1990 Jan 03; 85(1):55-61. PubMed ID: 2404028
    [Abstract] [Full Text] [Related]

  • 18. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb.
    Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B.
    Science; 1989 Jul 14; 245(4914):180-3. PubMed ID: 2665077
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression.
    Venturelli D, Travali S, Calabretta B.
    Proc Natl Acad Sci U S A; 1990 Aug 14; 87(15):5963-7. PubMed ID: 1696013
    [Abstract] [Full Text] [Related]

  • 20. Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells.
    Abaza MS, Al-Attiyah RJ, Al-Saffar AM, Al-Sawan SM, Moussa NM.
    Tumour Biol; 2003 Aug 14; 24(5):241-57. PubMed ID: 15001837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.